Idexx Pharmaceuticals Inc

Idexx Pharmaceuticals Inc
Share

Idexx Pharmaceuticals Inc

 •  January 8

“IDEXX’s market-leading innovation is at the core of our strategy,” said Jonathan Ayers, Chairman and Chief Executive Officer of IDEXX Laboratories. “Implementation of Applied BioCode’s technology supports our vision for margin expansion, and it will allow us to offer customers expanded test menu breadth and menu customization for each patient...

Idexx Pharmaceuticals Inc

 •  July 18, 2017

WESTBROOK, Maine, July 17, 2017 — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced the unanimous election of Stuart M. Essig as a member of the Company’s Board of Directors, effective July 12, 2017. In connection with Dr. Essig’s...

Idexx Pharmaceuticals Inc

 •  June 16, 2017

WESTBROOK, Maine, June 15, 2017—IDEXX is pleased to announce that rVetLink has joined the IDEXX family. rVetLink is a comprehensive referral management solution for specialty care hospitals that greatly streamlines the referral process between primary care and specialty care veterinarians. This expands IDEXX’s suite of technology applications for...

Idexx Pharmaceuticals Inc

 •  August 9, 2016

WESTBROOK, Maine, August 8, 2016 — IDEXX Laboratories, Inc. (NASDAQ: IDXX) will host its 2016 Investor Day on August 17-18, 2016 at its corporate headquarters in Westbrook, Maine. A live audio webcast and accompanying slide presentations will be available at www.idexx.com. An archived webcast replay of the event will be available approximately one...

Idexx Pharmaceuticals Inc

 •  June 21, 2016

The ImageVue™ DR50 Digital Imaging System uses state-of-the art technology to deliver diagnostic images in real-time at the point of care
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced the ImageVue™ DR50 Digital Imaging System, the first radiography system in veterinary medicine to enable low-dose radiation image capture without...

Idexx Pharmaceuticals Inc

 •  June 7, 2016

21-minute assay improves reproductive performance, enables bovine veterinarians to expand services
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today the launch of the Rapid Visual Pregnancy Test for cattle, a point-of-care test that can detect an open cow 28 days post-breeding, improving reproductive efficiency and profitability. With the new...

Idexx Pharmaceuticals Inc

 •  June 6, 2016

IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the William Blair 36th Annual Growth Stock Conference. Jonathan W. Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 14, 2016 at 11:30 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois....

Idexx Pharmaceuticals Inc

 •  April 29, 2016

IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the first quarter of 2016 of $418 million, an increase of 9% compared to the prior year period. Organic revenue growth for the quarter was 11%, supported by strong growth in the Companion Animal Group (“CAG”) and Water segments. Earnings per diluted share (“EPS”) for the quarter...

Idexx Pharmaceuticals Inc

 •  March 1, 2016

WESTBROOK, Maine, February 29, 2016 — IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 37th Annual Institutional Investors Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Tuesday, March 8, 2016 at 2:15 p.m....

Idexx Pharmaceuticals Inc

 •  January 18, 2016

IDEXX Neo™ streamlines work flows with easy-to-use, cost-effective cloud-based solution
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leader in cloud technology for veterinary practices, today announced a breakthrough cloud-based practice information management system (PIMS) called IDEXX Neo™ as part of their complete portfolio of PIMS offerings,...